What helps us in deciding on antidiabetic treatment for individual patients – case reports from routine clinical practice
Authors:
Zuzana Ondreičková 1; Martina Gubíková 2; Zbynek Schroner 3
Authors‘ workplace:
Diamel s. r. o., Trenčín
1; Dia vitae s. r. o., Košice
2; SchronerMed, s. r. o., Košice
3
Published in:
Diab Obez 2021; 21(41): 39-42
Category:
Case studies
Labels
Diabetology ObesitologyArticle was published in
Diabetes and obesity
2021 Issue 41
Most read in this issue
- Discordance between blood glucose and HbA1c – is an explanation possible according to the biokinetic model of glycation?
- Today we can influence overweight and obesity – and thus prevent their consequences, as is the development of diabetes or cardiovascular disease
- The potential of induced pluripotent stem cells in the study and treatment of monogenic diabetes
- News in the field of 2nd generation of basal insulin analogs in type 1 diabetes and data from continuous glucose monitoring